Showing posts with label SEC filing. Show all posts
Showing posts with label SEC filing. Show all posts

Monday, September 28, 2020

Reasons to Oppose the SEC's New 13F Proposal

The U.S. Securities and Exchange Commission (SEC) has proposed amendments to 13F filings.  Currently, investment managers with holdings of US securities totaling $100 million or more are required to file a 13F each quarter.  The proposal seeks to increase that level 35x to managers holding $3.5 billion or more.

The result?  A 90% reduction in the number of 13Fs filed.  This would reduce the number of hedge funds that file from 800 down to less than 100.  It would decrease total filers from around 5,283 to a mere 549.   $2.3 trillion in investment holdings would no longer be disclosed.

The proposal lays out the pros of making this change, so herein we'll examine the counterpoints to their arguments and the cons of making such a drastic change.  

There's also information at the bottom on how you can provide feedback to the SEC.  The deadline to submit comment is tomorrow (September 29th, 2020).


Counterpoints to the SEC's 13F Proposal

1) 13F Filing Costs For Managers Are Negligible

The SEC's main rationale for the proposal is that it would provide relief for smaller managers.  It argues that smaller managers that would no longer file 13Fs would save direct compliance costs that "could range from $15,000 to $30,000 annually per manager."

One hedge fund told us that at worst they see around $3,500 in costs per quarter to file a 13F, or around $14,000 per year, just below the low-end of the SEC's estimates.  Another hedge fund noted that costs and time associated with filing 13Fs are negligible.  Any 'relief' that would fall to smaller managers is de minimis, at best. 

Examining a hypothetical scenario of firms currently most impacted showcases this: a firm managing $100 million with only a 1% management fee and no performance fee theoretically earns $1 million in revenue a year.  Taking the SEC's highest estimate of yearly filing costs ($30,000) and dividing that by the firm's hypothetical yearly revenue ($1 million) means that annual filing costs would be only 3% of revenue.

And using the SEC's own estimates, that's the worst case scenario since it's the smallest firm required to file a 13F.  A $500 million firm in the same scenario would only spend 0.6% of its revenue on 13F filings a year, while a $1 billion firm would only spend 0.3% of revenue on 13F filings a year, and so on.   

Given the technological advancements implemented by the SEC such as XBRL and automation, it's easier and cheaper than ever to submit a 13F.  Filings are straightforward and not time consuming.



2)  It's Hard To Front-Run Someone 6 Weeks Later 

The proposal argues that there are also "indirect costs faced by smaller managers, such as those associated with potential front-running."

A frontrunner is defined as: one who trades “in front of an expected trade by another investor, thereby making the same trade on the terms the other investor would otherwise have got.” 

13Fs are filed with the SEC 45 days after quarter-end.  It's hard to front-run someone if you're receiving the information of their actions six weeks later.  This argument does not hold weight and would only apply to unique situations such as illiquid shares.  The time-delayed reporting of holdings via 13F filing already nullifies the vast majority of any potential front-running.

 

3)  Negative Consequences for Smaller Managers

The SEC must also consider the negative ramifications for smaller managers who would no longer file 13Fs.  Many limited partners utilize 13Fs to corroborate portfolio level details of managers they're invested in.  This helps prevent another Madoff situation and furthers transparency.

It would also reduce small manager discovery.  One institutional allocator told us that under the proposal, it would be increasingly difficult for them to consider investing in smaller managers due to the lack of transparency that otherwise aides in monitoring of potential managers to allocate capital to.



4)  Drastically Reduces Transparency & Limits Future Academic Research 

The loss of 90% of 13F filers and $2.3 trillion of investment holdings will drastically reduce market transparency and should be reason enough to reject the proposal.  It would also hinder academic research about markets and securities.  In a world that's becoming more data-driven by the day, going in the opposite direction is not progress.



5)  Capital Formation Exists in Current Setup

An argument can be made that the fact that X respected investor invests in Y stock leads to capital formation because other investors are then more inclined to examine and potentially invest in a company they might otherwise not have known about or bothered to look at.  This is particularly the case in small caps, where there's less sell-side coverage and less eyeballs on the companies in general.  

So capital formation can be achieved in the current structure because these managers are disclosing stakes in said companies. And again, due to the 45-day lag for disclosure, they are insulated from front-running.

And as far as we're aware, most investors want other people to be interested in and to buy the stocks they've already built stakes in.  Increased demand can lead to an increase in share price, thus benefiting the investor that already built a position, not burden them with increased costs as the proposal suggests.  

Idea sharing will happen regardless of the proposal or not via idea dinners, conferences, passing around quarterly letters, instant/direct messages, email, word of mouth, etc.  Humans by nature are mimetic beings.



6)  Investors & Companies Won't Know The Shareholder Base; Public Companies Will See Increased Costs & Time

Removing 90% of 13F filers drastically reduces the data available to companies as to who their shareholder base is, especially in small and mid cap names.  While major holders are revealed via 13D, 13G, and Form 4 filings, the rest of the shareholder base would become opaque.

When asked if the proposal would result in increased costs and time for their publicly traded company, one head of investor relations at a small cap replied, "Definitely." 

They also noted they're "not entirely sure how to prove who is actually a (share)holder" for companies that don't pay a dividend, while companies that do pay one can glean some potential insight.

Another investor relations professional said that the proposal would add costs for their company each year because they'll have to pay a firm to analyze trading activity in their shares to figure out the rest of the shareholder base.  And even then, this data wouldn't be accurate or even complete.

Investors also often want to know who their fellow shareholders are, particularly when it comes to hedge fund 'crowding.'

Also, the National Investor Relations Institute (NIRI) submitted a letter on behalf of 237 publicly traded companies, 26 investor relations consulting firms, and five industry associations.  All of them oppose the SEC's proposal.  This includes the likes of Sherwin-Williams, Mastercard, Chipotle, FedEx, Procter & Gamble, Marriott, Delta Air Lines, among many others.

Lastly, the NYSE along with 381 undersigned public companies also sent a letter opposing the proposal.



7)  Commissioner Allison Herren Lee Opposes the Proposal

Via a statement published on the SEC's website here, she writes:

"I am concerned that the projected cost savings in today’s proposal are greatly overstated and wholly inconsistent with the Commission’s past analysis—and, importantly, that the actual cost savings do not justify the loss of visibility into portfolios controlling $2.3 trillion in assets. Additionally, the Commission’s assertion of authority to raise the threshold conflicts with the plain text in the Exchange Act that requires us to collect the information. Specifically, section 13(f)(1) withholds authority from the Commission to raise the threshold, and the proposal fails to address that conflict."

 

8)  Negative Public Response

In a poll asking if the SEC's proposal was a good idea or not, 75% of respondents said it was a bad idea and 25% said it was a good idea.

A follow-up poll asked what the 13F filing threshold should be if the SEC is deadset on raising the limit:

62% of respondents said $500 million

29% of respondents said $1 billion

5% of respondents said the proposed $3.5 billion

4% of respondents said $5 billion or higher

Not to mention, the overwhelming majority of public comments the SEC has received thus far regarding the proposal have vehemently opposed it.  Here's a link to all the comments.

Additionally, here are a just a few of the headlines/articles reacting negatively to the proposal:

- Financial Times: SEC disclosure change would allow activists to 'go dark', lawyers warn

- Bloomberg: Goldman warns SEC proposal could shroud hedge fund crowding

- Nasdaq: President of Nasdaq says transparency is at risk with proposed changes to form 13F

- Harvard Law Forum on Corporate Governance: Adoption of the SEC’s current proposal would impede companies and their shareholders from promptly identifying the company’s institutional investors, hinder shareholder/public company engagement, and increase the potential for market abuse by sophisticated investors who wish to accumulate shares on a stealth basis

- Columbia Law School Blog on Corporations and the Capital Markets: Why the SEC's proposal to amend rule 13f-1 should fail

- National Investor Relations Institute: An average company would lose visibility into 55 percent of its current 13F filers and 69 percent of the hedge funds on its 13F list

- IHS Markit: An astounding 86% of (activist investors) would no longer be required to file 13F's

- CNBC: Jim Cramer rips SEC's proposed rule change for institutional investors


9)  Proposal Goes Against Original 13F Goals & SEC's Own Mission

Here are the original goals of the 13F (from page 9):

"The section 13(f) disclosure program had three primary goals. First, to create a central repository of historical and current data about the investment activities of institutional investment managers.  Second, to improve the body of factual data available regarding the holdings of institutional investment managers and thus facilitate consideration of the influence and impact of institutional investment managers on the securities markets and the public policy implications of that influence.  Third, to increase investor confidence in the integrity of the U.S. securities markets."

A higher reporting threshold resulting in a drastic reduction in the amount of data does not 'improve the body of factual data.'  It does the exact opposite.  Reduced transparency as a result of the proposal would decrease investor confidence, not increase it as the original goal states.  And the repository of historical data would be severely impaired going forward.

The SEC's own website lists its mission as:  "The mission of the SEC is to protect investors; maintain fair, orderly, and efficient markets; and facilitate capital formation. The SEC strives to promote a market environment that is worthy of the public's trust."

The proposal severely reduces transparency, which does not protect investors.  Such reduced transparency also erodes the environment of public trust that the SEC aims to achieve.

If the SEC is deadset on raising the filing threshold for the sake of modernization or to reduce its own burden, utilizing the inflation metric and setting the threshold at ~$500 million would reduce the number of filers by 50% (thus reducing any burdens on both the SEC & the smallest managers) while maintaining more transparency.  The poll above also shows this is more palatable than the proposal's $3.5 billion threshold. 

Simply put though, the negatives associated with the proposal greatly outweigh any perceived positives.

 

How to Provide Feedback to the SEC

The SEC is seeking input on the proposal and the deadline for comment is tomorrow (September 29th).  You can submit your feedback via these methods:

- Send an email to: rule-comments@sec.gov and make the Subject: S7-08-20

or

- Go to the comment page: https://www.sec.gov/rules/proposed.shtml?  and then click on "Submit comments on S7-08-20"



Thursday, October 31, 2019

Glenview Capital Trims Brookdale Senior Living Stake

Larry Robbins' Glenview Capital now owns 9.59% of Brookdale Senior Living (BKD) with over 17.63 million shares, per a 13G recently filed with the SEC.  This marks a slight decrease from the 18.43 million shares they owned at the end of the second quarter.  The filing was made due to portfolio activity on October 30th.

Per Yahoo Finance, Brookdale "owns and operates senior living communities in the United States. It operates through five segments: Independent Living, Assisted Living and Memory Care, CCRCs, Health Care Services, and Management Services."


ValueAct Capital Reduces Alliance Data Systems Position


Jeff Ubben's activist firm ValueAct Capital has also filed both a Form 4 and a 13D with the SEC regarding its stake in Alliance Data Systems (ADS). 

ValueAct now only owns 2.7% of the company with a little over 1.377 million shares.  This is down from the 3.7 million they reported owning back at the end of Q2.
The Form 4 filing notes that ValueAct converted its previously disclosed 150,000 shares of Series A non-voting convertible preferred stock into 1.5 million shares of common stock.  The 13D also indicates that ValueAct sold 2 million ADS shares at $101.50 on October 28th and sold another 1.83 million shares at $102 the next day.

Per Yahoo Finance, Alliance Data Systems "provides data-driven marketing and loyalty solutions worldwide."


Monday, October 21, 2019

Corvex Management Goes Activist on ForeScout Technologies

Keith Meister's hedge fund firm Corvex Management has filed a 13D with the SEC regarding shares of ForeScout Technologies (FSCT).  Per the filing, Corvex now owns 7.2% of ForeScout with over 3.34 million shares.  However, the 13D is being filed jointly with Jericho Capital Asset Management which also owns shares, bringing their collective exposure to 14.5% of the company with over 6.68 million shares.

The filing shows Corvex as buying throughout September and October initially at prices around $35.xx but really ramped up their buying when shares traded down to $25.xx.

The 13D also contains information about their new activist stance: "After the close of business on October 18, 2019, the Corvex Persons agreed with the Jericho Persons to work together to engage with the Issuer and its management regarding its business and prospects. The Corvex Persons and the Jericho Persons believe that combining their complementary expertise, skill sets and perspectives will be beneficial in discussions with the Issuer. The Corvex Persons and the Jericho Persons anticipate having private discussions with the Issuer as soon as practicable."

Per Yahoo Finance, ForeScout Technologies "provides network security products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. It offers CounterACT that provides for visibility and control capabilities across campus information technology and Internet of Things (IoT) devices, operational technology devices, data center physical and virtual devices, and cloud virtual devices; and SilentDefense, which offers visibility and control capabilities within the operational technology portion of the network."


Glenview Capital Files 13D on Meritor

Larry Robbins' hedge fund firm Glenview Capital has filed a 13D with the SEC on shares of Meritor (MTOR).  Per the filing, Glenview now owns 14.7% of the company with exposure to over 12.1 million shares.  This is inclusive of 4.9 million shares underlying call options.

This is up from the previous 7.2 million shares Glenview had exposure to at the end of the second quarter, per their most recent 13F filing.  So basically Glenview has added call option exposure and then gone activist on the name.

The filing also includes the standard activist investor boilerplate: "The Reporting Persons intend to engage in discussions with the Company and the Company’s management and board of directors, other shareholders of the Company and other interested parties on issues that may relate to the business, management, operations, assets, capitalization, financial condition, strategic plans, governance, board composition and the future of the Company.  Glenview Capital Management has entered into a customary confidentiality agreement with the Company in order to facilitate these discussions."

Per Yahoo Finance, Meritor "designs, develops, manufactures, markets, distributes, sells, services, and supports integrated systems, modules, and components to original equipment manufacturers (OEMs) and the aftermarket for the commercial vehicle, transportation, and industrial sectors. It operates through two segments, Commercial Truck; and Aftermarket, Industrial and Trailer."


Mantle Ridge Files Form 4 on CSX

Paul Hilal's investment firm Mantle Ridge LP has filed a Form 4 with the SEC regarding its stake in CSX (CSX).  Per the filing, Mantle Ridge sold 3.45 million shares on October 17th at $67.91.  The filing notes this was "in order to repay Mantle Ridge Fund obligations under a secured credit facility. The Reporting Persons have no current plans to sell any additional shares of the Issuer, although they reserve the right to do so in their discretion."

The Form 4 also shows Mantle Ridge made pro rata distributions of over 34.49 million shares to direct and indirect owners of the Mantle Ridge funds.  Also, 36,813 shares were contributed to certain charitable organizations.

Prior to founding Mantle Ridge, Hilal worked at Pershing Square and runs a similar activist strategy, though more concentrated.


Wednesday, September 18, 2019

ValueAct Sells Some KKR and CBRE Group

Jeff Ubben's investment firm ValueAct Capital has been active in markets recently.  We just highlighted how they went activist on LKQ and also sold some Arcosa.  Well, they've now also revealed two other portfolio moves.


ValueAct Trims KKR Stake

First, ValueAct has filed an amended 13D with the SEC regarding its stake in KKR (KKR).  It notes they sold shares in late July and also now in early September, with the bulk of their recent sales coming on September 13th at a weighted average price of $28.23. 

Per the filing, ValueAct now owns 8.8% of the company with 48.1 million shares.

Per Yahoo Finance, KKR is "a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments"


ValueAct Sells Some CBRE Group

Second, Ubben's firm has filed a Form 4 with the SEC regarding its position in CBRE Group (CBRE).  They sold 3 million shares on September 12th at $53.86.  After this transaction, they now own 10.22 million shares.

Per Yahoo Finance, CBRE Group is "operates as a commercial real estate services and investment company worldwide. It operates through Americas; Europe, Middle East and Africa; Asia Pacific; Global Investment Management; and Development Services segments. The company offers strategic advice and execution to owners, investors, and occupiers of real estate in connection with leasing; integrated property sales, and mortgage and structured financing services under the CBRE Capital Markets brand; and valuation services that include market value appraisals, litigation support, discounted cash flow analyses, and feasibility studies, as well as consulting services, such as property condition reports, hotel advisory, and environmental consulting. It also provides facilities management, project management, transaction management, and strategic consulting services to occupiers of real estate; and property management services comprising construction management, marketing, building engineering, accounting, and financial services for owners of and investors in office, industrial, and retail properties. In addition, the company provides investment management services under the CBRE Global Investors brand to pension funds, insurance companies, sovereign wealth funds, foundations, endowments, and other institutional investors; and development services under the Trammell Crow Company brand name primarily to users of and investors in commercial real estate. CBRE Group, Inc. was founded in 1906 and is headquartered in Los Angeles, California."


Monday, September 16, 2019

Carl Icahn Boosts Hertz Position

Activist investor Carl Icahn has filed numerous documents to the SEC recently (13D's and Form 4's) regarding his position in Hertz Global (HTZ).  Per the most recent 13D, Icahn now owns 30.92% of the company with exposure to over 43.92 million shares (inclusive of 2.03 million shares underlying forward contracts).

His recent purchases also are via forward contracts.  Per the filing, Icahn acquired exposure to over 1.15 million shares via forward contracts that expire on September 8, 2021.
The price per share is listed at $14.73 and $15 in the transactions.  And the filing notes that these contracts "Represents a forward price of $12 per Share, plus the amount per Share the Reporting Person paid the counterparty to the forward contract upon entering into such forward contract. The forward price is subject to adjustment to account for any dividends or other distributions declared by the Issuer. In addition, the Reporting Person paid a financing charge to the counterparty to such forward contract."


ValueAct Reveals Activist LKQ Stake, Sells Some Arcosa

Jeff Ubben's activist investment firm ValueAct Capital has filed a couple of 13D's with the SEC recently.

ValueAct Reveals Activist LKQ Stake

First, per a 13D regarding shares of LKQ Corp (LKQ), ValueAct now owns 5.2% of LKQ with over 16.03 million shares as of September 3rd.  This is a brand new position for the firm.

The filing indicates they were out buying shares throughout August and into early September with weighted average purchase prices coming between $24.91 and $27.49. 

The 13D also includes this note regarding their stake: "The Reporting Persons have had and anticipate having further discussions with officers and directors of the Issuer in connection with the Reporting Persons' investment in the Issuer. The topics of these conversations have covered or will cover a range of issues, including those relating to the business of the Issuer, management, board composition (which include whether it makes sense for a ValueAct Capital employee to be on the Issuer's board of directors), investor communications, operations, capital allocation, dividend policy, financial condition, mergers and acquisitions strategy, overall business strategy, executive compensation, and corporate governance."

Per Google Finance, LKQ "distributes replacement parts, components, and systems used in the repair and maintenance of vehicles. It operates in three segments: North America, Europe, and Specialty. The company distributes bumper covers, automotive body panels, and lights, as well as automotive glass products, such as windshields; salvage products, including mechanical and collision parts comprising engines; transmissions; door assemblies; sheet metal products, such as trunk lids, fenders, and hoods; lights and bumper assemblies; scrap metal and other materials to metals recyclers; and brake pads, discs and sensors, clutches, steering and suspension products, filters, and oil and automotive fluids, as well as electrical products, including spark plugs and batteries."


ValueAct Sells Some Arcosa Shares

Second, in a separately amended 13D, ValueAct has disclosed it has sold some Arcosa (ACA).  Per the 13D, the fund sold shares on September 9th through 13th at weighted average prices of around $34.50.

After the sales, ValueAct still owns 5% of the company with over 2.41 million shares.

Per Yahoo Finance, Arcosa "manufactures and sells infrastructure-related products and services for the construction, energy, and transportation markets. It operates through three segments: Construction Products Group, Energy Equipment Group, and Transportation Products Group. The Construction Products Group segment offers lightweight and natural construction aggregates, and trench shields and shoring products that are used in construction landscape, including commercial, industrial, road and bridge, and underground construction. It serves concrete producers; commercial, residential, industrial, and highway contractors; manufacturers of masonry products; state and local governments; and equipment rental dealers. The Energy Equipment Group segment provides structural wind towers for wind turbine producers; steel utility structures for electricity transmission and distribution; and pressurized and non-pressurized storage and distribution containers that store and transport various products, such as propane, anhydrous ammonia, and natural gas liquids. The Transportation Products Group segment offers hopper barges, tank barges, fiberglass covers, hatches, castings, and winches for commercial marine transportation companies and industrial shippers; axles, circular forgings, and coupling devices for freight, tank, locomotive, and passenger rail transportation equipment, as well as for other industrial uses; and cast components for use in the industrial and mining sectors. The company is headquartered in Dallas, Texas."


Tiger Global Still Buying Sunrun, Amends 13D Filing

As we've detailed previously, Chase Coleman's hedge fund firm Tiger Global has been out buying shares of Sunrun (RUN) in recent weeks.  In an amended 13D filing with the SEC, Tiger Global has now disclosed they own 22.2% of the company with over 26.05 million shares.

Their recent activity includes buying on September 9th through 11th at weighted average prices of around $15.093.

Per Yahoo Finance, Sunrun "engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. It also sells solar energy systems and products, such as panels and racking, as well as solar leads generated to customers. The company markets and sells its products through direct-to-consumer approach across online, retail, mass media, digital media, canvassing, field marketing, and referral channels, as well as its partner network. Sunrun Inc. was founded in 2007 and is headquartered in San Francisco, California."


Wednesday, September 11, 2019

Baupost Group Increases Translate Bio Stake

Seth Klarman's investment firm Baupost Group has filed a 13G with the SEC regarding its position in Translate Bio (TBIO).  Per the filing, Baupost now owns 24.06% of the company with over 12.27 million shares as of August 31st.  This is up from the 8.84 million shares they disclosed as of the end of June.

Per Yahoo Finance, Translate Bio is "a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 to treat ornithine transcarbamylase deficiency. It has a collaboration and license agreement with Sanofi Pasteur Inc. to develop mRNA vaccines for up to five infectious disease pathogens. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts."


Paulson & Co Files 13D on Callon Petroleum, Opposes Carizzo Oil Acquisition

John Paulson's hedge fund firm Paulson & Co has filed a 13D with the SEC regarding shares of Callon Petroleum (CPE).  Per the filing, Paulson now owns 9.5% of the company with over 21.59 million shares.  This is a brand new position for the hedge fund as they did not report any shares on their most recent 13F filing which discloses portfolios as of June 30th.

Paulson has gone activist and sent the board of directors a letter highlighting they oppose the acquisition of Carizzo Oil & Gas.  Paulson outlines a few reasons for their position: 1) Callon stock is down 36% since acquisition's announcement, 2) Co is offering an unwarranted premium to Carrizo, 3) Callon shareholders would be diluted, 4) Callon would no longer be a premium pure-play company, 5) Callon could be worth over 60%+ in a takeover, 6) Permian basin pure-plays remain attractive acquisition targets.  They go on to list other reasons as well.


Paulson & Co's Letter to Callon Petroleum

Embedded below is Paulson & Co's letter in its entirety.



You can also access it here.


Tiger Global Still Buying Sunrun Shares

Chase Coleman's hedge fund firm Tiger Global has filed yet another Form 4 with the SEC indicating their activity in Sunrun (RUN) shares.  As we've detailed previously, Tiger Global has been out buying RUN shares and they've continued to do so into September.

The latest filing indicates they were out buying 654,011 shares in total across September 4th through 6th with the bulk at weighted average prices of $15.247 and $15.501.

After these recent buys, Tiger Global now owns over 25.2 million shares of Sunrun.


Farallon Capital Shows DermTech Stake

Andrew Spokes' hedge fund firm Farallon Capital has filed a 13G with the SEC regarding shares of DermTech (DMTK).  Per the filing, Farallon now owns 9.8% of DermTech as of August 29th with exposure to over 1.23 million shares. 

Their stake is comprised of 615,385 shares and they also hold "Series A Preferred Shares (as defined in the Preliminary Note) convertible into an aggregate of 615,385 shares."

DermTech shares have been extremely volatile, plummeting from $21.69 in late August to around $5 by the end of the month.

Per Yahoo Finance, DermTech is "a molecular genomics company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company sells its products to pathology and oncology practitioners. DermTech, Inc. was incorporated in 1995 and is headquartered in La Jolla, California."


Wednesday, September 4, 2019

Tiger Global Continues To Buy Sunrun

Chase Coleman's hedge fund firm Tiger Global has filed yet another Form 4 with the SEC regarding their ownership of Sunrun (RUN).  We previously detailed last week how they were out buying RUN shares

Per the latest filing, Tiger Global was out acquiring more shares on August 29th, 30th, as well as September 3rd.  In total, they purchased 627,439 shares at weighted average prices of between $14.705 and $15.365.  After these buys, they now own over 24.55 million shares.

Per Yahoo Finance, Sunrun "engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. It also sells solar energy systems and products, such as panels and racking, as well as solar leads generated to customers. The company markets and sells its products through direct-to-consumer approach across online, retail, mass media, digital media, canvassing, field marketing, and referral channels, as well as its partner network. Sunrun Inc. was founded in 2007 and is headquartered in San Francisco, California."


Tuesday, September 3, 2019

TCI Fund Boosts Canadian Pacific Railway Stake

Sir Chris Hohn's TCI Fund management has filed an amended 13G with the SEC regarding its position in Canadian Pacific Railway (CP).  Per the filing, TCI Fund now owns 7.62% of the company with over 10.56 million shares as of August 23rd. 

This is up from the previous 10.15 million shares they owned at the end of June.  TCI has bought CP shares for seven consecutive quarters and their stake is now worth almost $2.5 billion.  They originally initiated the position in the first quarter of 2018.

It should also be noted that Hohn's firm also owns stakes in other railroads, such as Canadian National (CNI ~ $1.75 billion worth) and Union Pacific (UNP ~ $800 million worth), but their stake in CP is the most sizable.

Per Yahoo Finance, Canadian Pacific Railway "owns and operates a transcontinental freight railway in Canada and the United States. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; and merchandise freight, such as energy, chemicals and plastics, metals, minerals and consumer, automotive, and forest products. It also transports intermodal traffic comprising retail goods in overseas containers. The company offers rail and intermodal transportation services through a network of approximately 12,500 miles serving business centers in Quebec and British Columbia, Canada; and the United States Northeast and Midwest regions. Canadian Pacific Railway Limited was founded in 1881 and is headquartered in Calgary, Canada."


Friday, August 30, 2019

Lone Pine Capital Adds To Dominos Pizza Stake

Steve Mandel's hedge fund firm Lone Pine Capital has filed a 13G with the SEC regarding its stake in Dominos Pizza (DPZ).  Per the filing, Lone Pine now owns 5% of Dominos Pizza with over 2.07 million shares as of August 20th. 

This is up from the 1.24 million shares Lone Pine disclosed at the end of June when they established a new stake in the company.  DPZ shares have fallen from a high of $285 at the end of Q2 to recent lows around $226.

As a reminder, Steve Mandel stepped down from day-to-day management of the portfolio and handed those duties off to managers Dave Craver, Mala Gaonkar, and Kelly Granat (though others are also now listed on the SEC filings).

Per Yahoo Finance, Dominos Pizza "through its subsidiaries, operates as a pizza delivery company in the United States and internationally. It operates in three segments: U.S. Stores, International Franchise, and Supply Chain. The company offers pizzas under the Domino's brand name through company-owned and franchised stores. As of August 20, 2019, it operated through approximately 16,300 stores in 85 markets. The company was founded in 1960 and is headquartered in Ann Arbor, Michigan."


Dr. Michael Burry Buys More Tailored Brands, Sends Letter to Board

Dr. Michael Burry of Scion Asset Management has been busy lately.  We previously detailed how he re-built a stake in Gamestop (GME) and sent a letter to the board.  Well, he has now also just filed a 13D on shares of Tailored Brands (TLRD), which he's owned and previously also sent letters to the board.

The new filing indicates Burry has boosted his TLRD position, buying throughout August at prices of around $4.7145 and $4.8282.  In total, Scion Asset now owns 5.1% of the company with 2.6 million shares.  This is up from his previous stake of 1.85 million shares at the end of June.


Dr. Michael Burry Sends New Letter to Tailored Brands Board

Burry also sent a new letter to the board dated August 30th where he addresses rumors that Sycamore Partners had approached the company about an acquisition at around $10 per share.  Burry writes, "We do not know if any of this is true.  However, we believe you must know that $10 per share is not fair value and will not be acceptable to shareholders."

Later Burry goes on to write, "With some urgency, we stand by our letters of August 2nd and 19th. Given the quarter-century lows in the common stock and the severe undervaluation this entails, we believe the best use of funds from the corporate apparel segment sale, in good part or in full, is for a share repurchase.While management is considering asset sales, we would encourage exploring the market for Tailored’s Canadian operations. The Board and management ought to focus resources on its core 1300+ store U.S. operations. Proceeds from a sale of these remaining international operations may also be best used to accelerate debt repayment and stock buybacks."

He's previously sent two other letters to the board which you can read here and here.

Per Yahoo Finance, Tailored Brands "operates as a specialty apparel retailer the United States and Canada. It operates through two segments, Retail and Corporate Apparel. The Retail segment offers suits, suit separates, sport coats, slacks, formalwear, business casual, denim, sportswear, outerwear, dress shirts, shoes, and accessories for men. It also provides women's career and casual apparel, sportswear, and accessories; children's apparel; and alteration services. As of February 2, 2019, this segment operated 1,464 stores under the Men's Wearhouse, Men's Wearhouse and Tux, Jos. A. Bank, Moores, Joseph Abboud, and K&G brands. The Corporate Apparel segment provides corporate apparel uniforms and work wear to workforces under the Dimensions, Alexandra, Yaffy, and Twin Hill brands through various channels, including managed corporate accounts and catalogs, as well as through dimensions.co.uk, alexandra.co.uk, and twinhill.com Internet sites. This segment serves companies and organizations in the airline, retail grocery, retail, banking, quick service restaurant, car rental, distribution, travel and leisure, postal, security, healthcare, and public sectors. The company was formerly known as The Men's Wearhouse, Inc. and changed its name to Tailored Brands, Inc. in February 2016. Tailored Brands, Inc. was founded in 1973 and is based in Houston, Texas."


JANA Partners Buys Bloomin' Brands, FIles 13D

Barry Rosenstein's hedge fund firm JANA Partners has filed a 13D on shares of Bloomin' Brands (BLMN).  Per the filing, JANA now owns 9% of the company with over 7.81 million shares.  This is a brand new stake for the firm.

JANA was buying throughout August at with the bulk of their recent purchases coming at prices of around $16.08 and $16.21. 

The 13D contains the standard boilerplate:

"The Reporting Person acquired the Shares because it believes the Shares are undervalued and represent an attractive investment opportunity. The Reporting Person intends to have discussions with the Issuer’s board of directors and management regarding a sale of the Issuer, divestitures, capital allocation, operations and board composition. The Reporting Person expects to have discussions with the Issuer’s management and board of directors, shareholders and other interested parties relating to such matters."

Per Yahoo Finance, Bloomin' Brands, Inc., "through its subsidiaries, owns and operates casual, upscale casual, and fine dining restaurants in the United States and internationally. The company operates through two segments, U.S. and International. Its restaurant portfolio has four concepts, including Outback Steakhouse, a casual steakhouse restaurant; Carrabba's Italian Grill, a casual Italian restaurant; Bonefish Grill, an upscale casual seafood restaurant; and Fleming's Prime Steakhouse & Wine Bar, a contemporary steakhouse. As of December 30, 2018, the company owned and operated 1,068 restaurants and franchised 164 restaurants across 48 states; and owned and operated 125 restaurants and franchised 131 restaurants across 20 countries, Puerto Rico and Guam. Bloomin' Brands, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida."


Thursday, August 29, 2019

Glenview Capital Acquires More Tenet Healthcare

Larry Robbins' hedge fund firm Glenview Capital has filed a Form 4 with the SEC regarding shares of Tenet Healthcare (THC).  Per the filing, Glenview bought 81,368 shares on August 23rd at a weighted average price of $20.6965.  They now own over 19.43 million shares.

In a previous filing, they also were out buying on August 16th, purchasing 26,456 shares at a weighted average price of $19.8153.

Per Yahoo Finance, Tenet Healthcare is "a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; cardiothoracic surgery, neonatal intensive care, and neurosurgery services; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. As of December 31, 2018, the company operated 68 hospitals, 23 surgical hospitals, and approximately 475 outpatient centers, as well as 255 ambulatory surgery, 36 urgent care, and 23 imaging centers in the United States. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas."